Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Clozapine for the Prevention of Violence in Schizophrenia
Sponsor: NIMH
Enrolling: Male and Female Patients
Study Length: 6 Months
Clinic Visits: 27
IRB Number: 8206
U.S. Govt. ID: NCT05208190
Contact: Hannah Hesson: 646-774-5209 /
Additional Study Information: Do you have Schizophrenia, or Schizoaffective Disorder? You May Participate in a Research Study if: between the ages of 18 and 65, willing to take an FDA-approved antipsychotic medication, and do not have an allergy to clozapine. Reimbursement for travel expenses and time for: 3 initial outpatient visits (2-3 hours total), 24 weekly outpatient visits, Questionnaires, and blood draws. For more information about the study, contact: Hannah Hesson at 646-774-5209 or
This study is closed
Ragy Girgis, MD
Do You Qualify?
Are you between the ages of 18 and 65? Yes No
Are you willing to take an FDA approved antipsychotic medication? Yes No
Do you have an allergy to clozapine? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Hannah Hesson